
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+17
G Nine Bioceuticals is a leading Indian manufacturer of Pharmaceutical Formulations having Antibiotics in Beta Lactam Section. We are known for Quality Products at Affordable Price with Timely Delivery across the Indian & International Pharmaceutical Market. Our specialization in Potassium Clavulanate namely Amoxy+Clav., Cefixime+Clav., Cefpodoxime+Clav., Cefuroxime+Clav. and other formulations too like Ceftriaxone & Sulbactam/Tazobactam, Ceftazidime & Tazobactum, Cefoperazone & Sulbactam/Tazobactam, Meropenem & Sulbactam, Cefepime, Piperacillin & Tazobactam, Cefotaxim & Sulbactam, Ampicillin & Sulbactam/Cloxacillin, Amoxycillin & Dicloxacillin and Ceftiofur etc. in form of Tablets, Dry Syrups, Dry Injections and Veterinary Dry Injections. We have most modern facilities & technologies and highly...
Antibiotics in beta lactam section,potassium clavulanate,amoxycillin & clavulanic acid,cefixime & potassium clavulanate,cefpodoxime proxetil & potassium clavulanate,cefuroxime axetil & potassium clavulanate,cephalexin,ceftriaxone & sulbactam/tazobactam,ceftazidime & tazobactam,cefoperazone & sulbactam/tazobactam,cefuroxime & sulbactam,meropenem & sulbactam,cefepime & tazobactam,pipracillin & tazobactam,cefotaxim & sulbactam,cefoperazone & sulbactam,ampicillin & sulbactam, ampicillin & cloxacillin,amoxycillin & sulbactam,amoxycillin & cloxacillin,amoxycillin & dicloxacillin,and ceftiofur
G nine bioceuticals pvt. ltd operates in the Pharmaceutical manufacturing industry.
G nine bioceuticals pvt. ltd's revenue is 11m - 100m
G nine bioceuticals pvt. ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.